NEW: Redenlab commence work with Royal Melbourne Hospital on mobile speech recording in multiple sclerosis

In collaboration with the Movement Disorders and Cognitive monitoring in MS group. Speech is being used as an outcome measure in a treatment trial for Tremor in MS.

Tags: , , ,

Related Post

Childhood apraxia of speech clinical trial

  • Posted on 24 October, 2023
    Speech disorders impacting children have debilitating impacts on educational, social and later employment outcomes. There are limited therapeutic options for...
    Read more

    Researchers working towards finding a new treatment for Spinocerebellar Ataxia Type 1 (SCA1)

    • Posted on 24 October, 2023
      Spinocerebellar ataxia Type 1 (SCA1) is a dominantly inherited neurodegenerative disease resulting in balance, speech, thinking and coordination difficulties. SCA1...
      Read more

      The FA App

      • Posted on 24 October, 2023
        Friedreich ataxia (FA) is a progressive, genetically inherited multisystem disease that affects children and adults. FA leads to significant changes...
        Read more